English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

METHODS: Forty-one consecutive patients undergoing open cranial vault remodeling were retrospectively reviewed. Early in the series, individual anesthesiologist preference dictated aminocaproic acid (ACA) use, and no patients received erythropoietin (EPO). After protocol initiation, all patients were evaluated for EPO and all patients received intraoperative ACA. Transfusion guidelines were defined. Cell Saver device was used when possible. Comparisons were made between the new protocol “ACA+EPO Group” (received ACA, received EPO), the pre-protocol “ACA Only Group” (received ACA, did not receive EPO), and the pre-protocol “No ACA Group” (did not receive ACA, did not receive EPO). Tukey’s HSD Test was used to compare groups on patient characteristics, estimated blood loss (EBL), and allogeneic packed red blood cell transfusion volume.

Abstract: Striving for Transfusion-Free Open Cranial Vault Remodeling: A Novel Protocol